glp-1 trials 3 Takeaways from the Landmark Oral 'Switch' Trial for Obesity Care GLP-1 Medications for Weight Loss:

Read Blog How IV Therapy Can Boost Your Wellness and Recovery Learn how IV therapy supports hydration, recovery, immunity, and overall wellness with targeted nutrient infusions

, French, P

WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk

and Blue KC Announce Affiliation Agreement Affiliation Announcement: Highmark and Blue KC plan to affiliate, pending regulatory approval, to improve efficiency, expand capabilities, and make health care more affordable

It helps regulate appetite and blood sugar by signaling fullness, slowing stomach emptying, and supporting insulin response

Its not clear if there is something unique about this class of drugs that leads to specific outcomes on the muscle, whether its a loss of mass or an improvement in muscle function and performance